Company Overview and News

0
PCAR / PACCAR, Inc. 11-K

2018-06-15 sec.gov
pcar-11k_20171231.htm .
PCAR

264
45 'Safer' Dividend Nasdaq Equities For June

2018-06-11 seekingalpha
45 of 52 NASDAQ Index dividends were presumed "safer" because they showed positive one-year returns and free cash flow yields greater than dividend yields as of 6/7/17.
LRCX AMGN VOD VOD GILD CMCSA WDC STX PCAR KLAC HAS VODPF AMAT AVGO CSCO QCOM MXIM PAYX

0
Want To Take A Ride With Special Dividend Payers?

2018-06-07 seekingalpha
PCAR evolves in a highly cyclical industry where trucks are either in high demand or nobody wants to buy one.
PCAR

0
PCAR / PACCAR, Inc. SD

2018-05-31 sec.gov
SD SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PCAR

99
Top Analyst Upgrades and Downgrades: Biogen, Box, Corning, GrubHub, Hyatt, Quality Systems, Zillow and More

2018-05-31 247wallst
The futures traded slightly higher Thursday morning as investors digested Wednesday’s huge rally, which basically rode on the back of the political situation in Italy cooling off some and Italian sovereign bond yields, which had skyrocketed, coming back to earth some.
H GLW MS.PRE MS.PRF QSII MS.PRG PCAR MS.PRA DSW MS.PRI BIIB GRUB MS.PRK BOX TRI MS

35
The Wall Of Worry Looks A Little Higher At Cummins

2018-05-31 seekingalpha
Cummins has been posting strong revenue growth as healthy cycles overlap in trucks, construction equipment, and energy, but warranty costs are chewing into peak profits.
JMPLY PCAR DMLRY JMPLF CMI

0
PCAR / PACCAR, Inc. FORM 8-K (Current Report)

2018-05-16 sec.gov
Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PCAR

318
The Good News In Tuesday's Selloff

2018-05-16 seekingalpha
In one sense, Tuesday's market action was a risk parity investor's bad dream: both stocks and bonds saw price declines.
STT STT.PRC STT.PRE STT.PRD MS.PRE STT.PRG MS.PRF MS.PRG PCAR UTX MS.PRA CMI SPYR BRK.A SGLRF MS.PRI BK MS.PRK AAPL MSFT MS XSPY

21
Shrug Off Negative News, Tesla's Still a Buy

2018-05-14 zacks
Another Tesla (TSLA - Free Report) Autopilot executive has left the company for rival Waymo. According to media reports, Matthew Schwall is now a part of Alphabet (GOOGL - Free Report) company Waymo's safety team led by former National Highway Traffic Safety Administration (NHTSA) Deputy Administrator Ron Medford.
FOXF GOOGL GM.WS.A GM.WS.B GM.WS.C PCAR GM INTC GM.WSB

22
Auto Stock Roundup: TM Earnings Beat, Ford's Mexico Production Falls

2018-05-10 zacks
Auto companies’ increasing preference for sports utility vehicles (SUVs) and trucks are reshaping the industry. Even concerns over high interest rates and growing oil prices could not stop Americans from splurging on SUVs and pickup trucks. This has led to strong unit sales of SUVs, crossovers and pickup trucks. In the past week, a news regarding Ford Motor Company’s (F - Free Report) declining vehicle production in Mexico surfaced as the company planned to exit the sedan market of the United States.
AXL TM TYT PCAR TOYOF GM.WS.A GM.WS.B GM.WS.C 7203 GM GM.WSB AAP SUP

35
Commercial Vehicle Group Finally Seeing Margin Leverage As The Peak Approaches

2018-05-07 seekingalpha
CVGI is seeing good volume and stronger margins on very healthy volumes of commercial trucks and construction equipment, with significant improvements in the GCA business.
CVGI PCAR CMI

0
PCAR / PACCAR, Inc. FORM 8-K (Current Report)

2018-05-04 sec.gov
Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PCAR

51
Margin Leverage Can Drive Parker-Hannifin Higher, But The Outlook Is A Little Murky

2018-05-04 seekingalpha
Parker-Hannifin had one of the better quarterly earnings reports, even if incremental margins in North American Industrial weren't as strong as hoped.
PH CAT CLC PCAR DE

0
PCAR / PACCAR, Inc. 10-Q (Quarterly Report)

2018-05-04 sec.gov
pcar-10q_20180331.htm UNITED STATES
PCAR

3
North American April semi-truck orders up 47 pct, dip from Q1

2018-05-03 reuters
DETROIT (Reuters) - North American orders for Class 8 semi-trucks jumped nearly 50 percent in April as trucking companies struggled to add capacity in a tight U.S. freight market, but the pace of orders cooled from highs seen in the first quarter, FTR, a company that tracks the industry, said on Thursday.
NAV NAV.PRD VOLVF PCAR VOLVY DDAIF VOLAF VLVLY

Related Articles

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

STML: Stemline Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...

Silicon Investor Message Boards

This table lists all message boards related to PCAR / PACCAR, Inc. on message board site Silicon Investor.

ZIP ZipCar Car Sharing Service
CUSIP: 693718108